LakeShore Biopharma
Quarterly Financials
| Values in thousands | 2024-03-31 |
|---|---|
Revenue | $135,527 |
Gross Profit | 34,408 |
EBITDA | -82,617 |
EBIT | -93,163 |
Net Income | -181,410 |
Net Change In Cash | 135,527 |
Cash | 246,351 |
Basic Shares | 99,990 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $614,961 | $573,418 | $687,201 | $502,949 |
Gross Profit | 507,189 | 455,729 | 533,840 | 385,883 |
EBITDA | -48,538 | -368,663 | -76,800 | -67,195 |
EBIT | -85,189 | -410,848 | -113,487 | -98,349 |
Net Income | -99,982 | -433,464 | -145,479 | -545 |
Net Change In Cash | 614,961 | 573,418 | 687,201 | 502,949 |
Free Cash Flow | -138,840 | -339,480 | -239,519 | -299,545 |
Cash | 28,083 | 246,351 | 370,108 | 885 |
Basic Shares | 106,923 | 106,923 | 77,421 | 29,500 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$13.40 |
2024-03-31 | -$8.30 |
2023-12-31 | -$11.28 |
2023-09-30 | -$11.28 |
